Eventos cardíacos adversos tras la vacunación con COVID-19 ARNm: Una revisión sistemática y metaanálisis

Translated title of the contribution: Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis

E.A.C. Putri*, M. Munir, H.K. Setiawan, L. Herawati, G.M. Sari, C.D.K. Wungu, H. Susilo, H. Sutanto

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

Context: Although have been proven able to control the prevalence of coronavirus disease-19 (COVID-19), Pfizer-BioNTech and Moderna COVID-19 vaccines are reported to have possible side effects on the heart. Aims: To know the magnitude of adverse events in the cardiac after messenger ribonucleic acid (mRNA)-based vaccination. Methods: An electronic search in PubMed, Web of Science, Scopus, and Ebsco/Cinahl was performed. The keywords were: “COVID-19 vaccine”, “SARS-CoV-2 vaccine”, “myocarditis”, “myopericarditis”, “pericarditis”, “myocardial infarction”, and “myocardial injury”. The electronic search was updated until March 2022. STATA/MP Statistical Software: Release 14 (StataCorp LLC, College Station, Texas) was used in this study to perform a meta-analysis of a random-effect for myocarditis, pericarditis, myocarditis, myocardial infarction, and myocardial injury. Results: Twenty-one case reports/case series studies with a total of 62 individuals who had been vaccinated against COVID-19 mRNA (Pfizer-BioNTech and Moderna) were included in the systematic review. Whereas seven observational cohort studies had 170,053,333 people who had been vaccinated, 245 of whom had myocarditis. In addition, two observational cohort studies with 13,948,595 vaccinated individuals, 16 of whom developed pericarditis. There was only one observational cohort study that had a total of 7,183,889 people who had been vaccinated and 11 had myopericarditis. Based on the pooled incidence, the result is <0.002%. Conclusions: The Pfizer-BioNTech and Moderna vaccines have a low incidence of myocarditis. Men are more likely to develop post-COVID-19 myocarditis with an average age of 22 years and in the age range of 21-40 years. The type of mRNA COVID-19 vaccine that causes myocarditis the most is Pfizer. The diagnosis of myocarditis is mostly made by troponin examination. COVID-19 mRNA vaccination has a low incidence of myocarditis.

Translated title of the contributionAdverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
Original languageSpanish
Pages (from-to)76-100
Number of pages25
JournalJournal of Pharmacy and Pharmacognosy Research
Volume11
Issue number1
DOIs
Publication statusPublished - 1 Jan 2023

Keywords

  • cardiac disease
  • cardiac events
  • COVID-19
  • mRNA vaccines
  • SARS-CoV-2
  • ACUTE MYOCARDITIS
  • UNITED-STATES
  • VACCINES
  • SEX
  • ASSOCIATION
  • PROGNOSIS
  • DIAGNOSIS
  • ERA

Cite this